desensitization protocols - michigan medicinedesensitization protocols see also, umhhc policy...

26
DESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017. Desensitization Policy for Drug Hypersensitivity for Inpatients for information regarding dosing intervals, infusion times, IV access requirements and monitoring. CONTENTS Amiodarone Ampicillin Ampicillin/Sulbactam Aspirin Atovaquone Aztreonam Cefazolin Cefepime Ceftazidime Ceftriaxone Ciprofloxacin Clopidogrel Levofloxacin Linezolid Meropenem Metronidazole Nafcillin Penicillin G Piperacillin/Tazobactam Tigecycline Vancomycin

Upload: others

Post on 08-Apr-2020

14 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

DESENSITIZATION PROTOCOLS

See also, UMHHC Policy 07-01-017. Desensitization Policy for Drug Hypersensitivity for Inpatients for information regarding dosing intervals, infusion times, IV access requirements and monitoring.

CONTENTS

Amiodarone

Ampicillin

Ampicillin/Sulbactam

Aspirin

Atovaquone

Aztreonam

Cefazolin

Cefepime

Ceftazidime

Ceftriaxone

Ciprofloxacin

Clopidogrel

Levofloxacin

Linezolid

Meropenem

Metronidazole

Nafcillin

Penicillin G

Piperacillin/Tazobactam

Tigecycline

Vancomycin

Page 2: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 2 of 26

AMIODARONE

STEP 1: PHARMACY – PREPARE AND LABEL SERIAL DILUTIONS

STEP 2: PHARMACY - PREPARE IV DOSES Goal dose 150 mg:

Dose # Dose Volume Bag #

1 0.01 mg 1 mL Bag 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 10 mL

5 0.3 mg 30 mL

6 1 mg 1 mL Bag 2 (1 mg/mL)

7 3 mg 3 mL

8 5 mg 5 mL

9 10 mg 10 mL

10 30 mg 30 mL

11 (cumulative 150 mg) 100 mg 100 mL

Goal dose 300 mg:

Dose # Dose Volume Bag #

1 0.01 mg 1 mL Bag 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 10 mL

5 0.3 mg 30 mL

6 1 mg 1 mL Bag 2 (1 mg/mL)

7 3 mg 3 mL

8 5 mg 5 mL

9 10 mg 10 mL

10 30 mg 30 mL

11 100 mg 100 mL

12 (cumulative 300 mg) 150 mg 100 mL Bag 1 (1.5 mg/mL)

Note: Doses should be given 30 minutes apart

Bag Concentration

1. Remove 13 mL out of 100 mL D5W bag

2. Inject 150 mg/3 mL of amiodarone into 100 mL D5W (Bag #1) 1.5 mg/mL

3. Remove 12 mL out of 100 mL D5W bag

4. Inject 100 mg/2 mL of amiodarone into 100 mL D5W (Bag #2) 1 mg/mL

5. Remove 11 mL out of 100 mL D5W Bag #2

6. Inject 1 mL of Bag #1 into 100 mL D5W (Bag #3) 0.01 mg/mL

Page 3: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 3 of 26

Ampicillin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g AMPICILLIN vial with 9.5 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, label vial #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, label vial #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g:

Dose # Dose Volume Vial #

1 0.01 mg 1 mL #3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL #2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL #1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Goal dose 2 g:

Dose # Dose Volume Vial #

1 0.01 mg 1 mL #3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL #2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL #3 (100 mg/mL

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g Add-Vantage 1 g Add-Vantage vial assembled with 50 mL NS

Page 4: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 4 of 26

Ampicillin/Sulbactam

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 3 g Unasyn vial with 6.4 mL NS, label vial #1 375 mg/mL

2. 4 mL of vial 1 plus 11 mL NS into an empty vial, label vial #2 100 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL NS into an empty vial, label vial #3 1 mg/mL

4. 0.1 mL of vial 3 plus 9.9 mL NS into an empty vial, label vial #4 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal 1.5 g

Dose # Dose Volume Vial #

1 0.015 mg 1.5 mL 4 (0.01 mg/mL) 2 0.03 mg 3 mL

3 0.15 mg 0.15 mL 3 (1 mg/mL)

4 0.3 mg 0.3 mL

5 1.5 mg 1.5 mL

6 3 mg 3 mL

7 4.5 mg 4.5 mL

8 15 mg 0.15 mL 2 (100 mg/mL)

9 30 mg 0.3 mL

10 45 mg 0.45 mL

11 150 mg 1.5 mL

12 300 mg 3 mL

13 450 mg 4.5 mL

14 cumulative 1.5 g 500 mg 1.33 mL 1 (375 mg/mL)

Goal 3 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 4 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.1 mg 0.1 mL 3 (1 mg/mL)

4 0.3 mg 0.3 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 10 mg 0.1 mL 2 (100 mg/mL)

8 30 mg 0.3 mL

9 100 mg 1 mL

10 300 mg 3 mL

11 1 g 2.67 mL 1 (375 mg/mL)

12 cumulative 3 g 1.5 g Add-Vantage 1.5 g Add-Vantage assembled with 50 mL NS

Page 5: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 5 of 26

ASPIRIN

STEP 1: ADMINISTER ASPIRIN DOSES USING ASPIRIN TABLETS

Dose # Dose Dosage Form

1 20.25 mg ¼ of 81 mg tab

2 40.5 mg ½ of 81 mg tab

3 40.5 mg ½ of 81 mg tab

4 81 mg 81 mg tab

5 121.5 mg 1 ½ 81 mg tab

6 202.5 mg 2 ½ 81 mg tab

7 325 mg 325 mg tab

Notes: Doses are to be given orally Doses should be given 90 – 180 minutes apart Patient must not react to a dose before moving on to an escalating dose Reference: White AA, Stevenson DD, Woessner KM, et al. Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc. 34:138-142, 2013.

Page 6: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 6 of 26

Atovaquone Oral Suspension (150 mg/mL)

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. 1 mL of stock suspension (150 mg/mL) mixed with 14 mL SW, labeled #1 10 mg/mL

2. 1 mL of vial #1 plus 9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 1 mL of vial #2 plus 9 mL SW into an empty vial, labeled #3 0.1 mg/mL

STEP 2: PREPARE PO DOSES Goal 750 mg

Dose # Dose Volume Vial #

1 0.1 mg 1 mL 3 (0.1 mg/mL) 2 0.3 mg 3 mL

3 0.5 mg 5 mL

4 1 mg 1 mL 2 (1 mg/mL)

5 3 mg 3 mL

6 5 mg 5 mL

7 10 mg 1 mL 1 (10 mg/mL) 8 30 mg 3 mL

9 50 mg 5 mL

10 100 mg 0.67 mL Stock suspension (150 mg/mL)

11 500 mg 3.33 mL

Goal 1.5 g

Dose # Dose Volume Vial #

1 0.1 mg 1 mL 3 (0.1 mg/mL) 2 0.3 mg 3 mL

3 0.5 mg 5 mL

4 1 mg 1 mL 2 (1 mg/mL)

5 3 mg 3 mL

6 5 mg 5 mL

7 10 mg 1 mL 1 (10 mg/mL) 8 30 mg 3 mL

9 50 mg 5 mL

10 100 mg 0.67 mL Stock suspension (150 mg/mL)

11 500 mg 3.33 mL

12 750 mg 5 mL

Page 7: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 7 of 26

Aztreonam

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g AZTREONAM vial with 10 mL SW. Label as vial #1. 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.1 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 1 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g 1 g vial in 50 mL

Corrected August 7, 2013.

Page 8: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 8 of 26

Cefazolin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g CEFAZOLIN vial with 9.6 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial , labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 500 mg

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 5 mg 5 mL

7 10 mg 0.1 mL 1 (100 mg/mL)

8 30 mg 0.3 mL

9 50 mg 0.5 mL

10 100 mg 1 mL

11 300 mg 3 mL

Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Page 9: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 9 of 26

Cefazolin, continued Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 1 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g 1 g Add-Vantage in 50 mL

Page 10: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 10 of 26

Cefepime

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g CEFEPIME vial with 10 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 1 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g over 30 min Mini-bag plus or Add-Ease

Page 11: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 11 of 26

Ceftazidime

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g CEFTAZIDIME vial with 10 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 500 mg

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 5 mg 5 mL

7 10 mg 0.1 mL 1 (100 mg/mL)

8 30 mg 0.3 mL

9 50 mg 0.5 mL

10 100 mg 1 mL

11 300 mg 3 mL

Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Page 12: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 12 of 26

Ceftazidime, continued

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 1 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g Add-Vantage

Page 13: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 13 of 26

Ceftriaxone

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g CEFTRIAXONE vial with 9.6 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg 3 mL

13 500 mg 5 mL

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 3 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg 3 mL

15 500 mg 5 mL

16 1 g Add-Vantage

Page 14: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 14 of 26

Ciprofloxacin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Inject 0.5 mL Cipro (2 mg/mL) plus 9.5 mL D5W into an empty vial labeled #1 0.1 mg/mL

2. 1 mL of vial 1 plus 9 mL D5W into an empty vial labeled #2 0.01 mg/mL

3. 1 mL of vial 2 plus 9 mL D5W into an empty vial labeled #3 0.001 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 400 mg

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 2 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 1 mL 1 (0.1 mg/mL)

4 0.5 mg 5 mL

5 1 mg 0.5 mL Bag (2 mg/mL)

6 5 mg 2.5 mL

7 10 mg 5 mL

8 20 mg 10 mL

9 50 mg 25 mL

10 100 mg 50 mL

11 200 mg over 60 min 200 mg premix bag

Page 15: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 15 of 26

CLOPIDOGREL

STEP 1: PHARMACY - PREPARE AND LABEL SERIAL DILUTION SOLUTIONS

Directions Concentration

1. Triturate 1 clopidogrel 75 mg tablet into a fine powder. Transfer powder to a 100 mL graduated cylinder. Rinse remaining powder in mortar with sterile water for irrigation and transfer to graduate. Add q.s. to 25 mL with sterile water for irrigation. Label graduate solution #1

3 mg/mL

2. Transfer 1 mL of clopidogrel 3 mg/mL solution to a new graduated cylinder plus 29 mL sterile water for irrigation. Label as solution #2

0.1 mg/mL

Goal dose 75 mg (please note all doses solution)

Dose # Dose Volume Vial #

1 0.02 0.2 mL 2 (0.1 mg/mL)

2 0.05 0.5 mL

3 0.15 1.5 mL

4 0.5 5 mL

5 1.5 0.5 mL 1 (3 mg/mL)

6 5 1.7 mL

7 15 5 mL

8 45 15 mL

Notes: Doses are to be given orally Doses should be given 30 minutes apart Initiate 75 mg clopidogrel 24 hours later. Reference: Sanchez-Lopez J, Munoz-Cano R, Bartra A, et al. Desensitization to clopidogrel: a growing need. Allergy. 65 (2010); 274-280.

Page 16: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 16 of 26

Levofloxacin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Inject 1 mL LEVOFLOXACIN (5 mg/mL) plus 9 mL SW 0.5 mg/mL

2. 1 mL of vial 1 plus 9 mL SW into an empty vial, labeled #2 0.05 mg/mL

3. 1 mL of vial 2 plus 9 mL SW into an empty vial, labeled #3 0.005 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 500 mg

Dose # Dose Volume Vial #

1 0.01 mg 0.2 mL 2 (0.05 mg/mL)

2 0.05 mg 1 mL

3 0.1 mg 2 mL

4 0.5 mg 1 mL 1 (0.5 mg/mL)

5 1 mg 2 mL

6 5 mg 1 mL Bag (5 mg/mL)

7 10 2 mL

8 30 mg 6 mL

9 50 mg 10 mL

10 100 mg 20 mL

11 300 mg over 60 minutes 60 mL

Goal dose 750 mg

Dose # Dose Volume Vial #

1 0.01 mg 0.2 mL 2 (0.05 mg/mL)

2 0.05 mg 1 mL

3 0.1 mg 2 mL

4 0.5 mg 1 mL 1 (0.5 mg/mL)

5 1 mg 2 mL

6 5 mg 1 mL Bag (5 mg/mL)

7 10 mg 2 mL

8 25 mg 5 mL

9 50 mg 10 mL

10 75 mg 15 mL

11 100 mg 20 mL

12 500 mg over 60 minutes 500 mg premix bag

Page 17: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 17 of 26

LINEZOLID

STEP 1: PHARAMCY - PREPARE AND LABEL SERIAL DILUTIONS

STEP 2: PHARMACY - PREPARE IV DOSES Goal dose 600 mg

Dose # Dose Volume Rate Bag #

1 0.03 mg 1.5 mL 18 mL/h #3 (0.02 mg/mL)

2 0.07 mg 3.5 mL 42 mL/h

3 0.15 mg 0.75 mL 9 mL/h #2 (0.2 mg/mL)

4 0.3 mg 1.5 mL 18 mL/h

5 0.6 mg 3 mL 36 mL/h

6 1.2 mg 6 mL 72 mL/h

7 2.3 mg 1.2 mL 13.8 mL/h #1 (2 mg/mL)

8 4.7 mg 2.3 mL 28.2 mL/h

9 9.4 mg 4.7 mL 56.4 mL/h

10 18.75 mg 9.4 mL 112.5 mL/h

11 37.5 mg 18.8 mL 225 mL/h

12 75 mg 37.5 mL 450 mL/h

13 150 mg 75 mL 300 mL/h

14 300 mg 150 mL 600 mL/h

Note: Infuse doses 1-12 over five minutes and infuse doses 13-14 over fifteen minutes; wait ten minutes between each dose Reference: Bagwell AD, Stollings JL, White KD, et al. Linezolid desensitization for a patient with multiple medication hypersensitivity reactions. Ann Pharmacother. 2013; 47:e30.

Bag Concentration

1. Premixed bag of linezolid 600 mg/300 mL of D5W, label #1 2 mg/mL

2. 10 mL from bag 1 plus 90 mL D5W, labeled #2 0.2 mg/mL

3. 10 mL from bag 2 plus 90 mL D5W, labeled #3 0.02 mg/mL

Page 18: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 18 of 26

Meropenem

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g MEROPENEM vial with 20 mL SW label vial #1 50 mg/mL

2. 0.2 mL of vial 1 plus 19.8 mL SW into an empty vial, labeled #2 0.5 mg/mL

3. 0.2 mL of vial 2 plus 19.8 mL SW into an empty vial, labeled #3 0.005 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 500 mg

Dose # Dose Volume Vial #

1 0.01 mg 2 mL 3 (0.005 mg/mL)

2 0.05 mg 10 mL

3 0.1 mg 0.2 mL 2 (0.5 mg/mL)

4 0.5 mg 1 mL

5 1 mg 2 mL

6 5 mg 10 mL

7 10 0.2 mL 1 (50 mg/mL)

8 30 mg 0.6 mL

9 50 mg 1 mL

10 100 mg 2 mL

11 300 mg 6 mL

Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 2 mL 3 (0.005 mg/mL)

2 0.05 mg 10 mL

3 0.1 mg 0.2 mL 2 (0.5 mg/mL)

4 0.5 mg 1 mL

5 1 mg 2 mL

6 3 mg 6 mL

7 5 mg 10 mL

8 10 mg 0.2 mL 1 (50 mg/mL)

9 30 mg 0.6 mL

10 50 mg 1 mL

11 100 mg 2 mL 1 (50 mg/mL)

12 300 mg 6 mL

13 500 mg 10 mL

Page 19: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 19 of 26

Meropenem, continued

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 2 mL 3 (0.005 mg/mL)

2 0.03 mg 6 mL

3 0.05 mg 10 mL

4 0.1 mg 0.2 mL 2 (0.5 mg/mL)

5 0.3 mg 0.6 mL

6 0.5 mg 1 mL

7 1 mg 2 mL

8 3 mg 6 mL

9 5 mg 10 mL

10 10 mg 0.2 mL 1 (50 mg/mL)

11 30 mg 0.6 mL

12 50 mg 1 mL

13 100 mg 2 mL

14 300 mg 6 mL

15 500 mg 10 mL

16 1 g Mini-Bag Plus or Add-Ease

Page 20: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 20 of 26

METRONIDAZOLE

STEP 1: PHARMACY - PREPARE AND LABEL SERIAL DILUTIONS

Bag/Vial Concentration

1. Use metronidazole 500 mg/100 mL pre-manufactured IV bag. Label as Bag #1. 5 mg/mL

2. 1 mL of Bag #1 plus 9 mL NS into an empty vial, labeled #2 0.5 mg/mL

3. 1 mL of vial #2 plus 9 mL NS into an empty vial, labeled #3 0.05 mg/mL

4. 1 mL of vial #3 plus 9 mL NS into an empty vial, labeled #4 0.005 mg/mL

STEP 2: PHARMACY - PREPARE IV DOSES Goal dose 500 mg

Dose # Dose Volume Bag/Vial #

1 0.005 mg 1 mL 4 (0.005 mg/mL)

2 0.015 mg 3 mL

3 0.05 mg 1 mL 3 (0.05 mg/mL)

4 0.15 mg 3 mL

5 0.5 mg 1 mL 2 (0.5 mg/mL)

6 1.5 mg 3 mL

7 5 mg 1 mL

1 (5 mg/mL)

8 25 mg 5 mL

9 50 mg 10 mL

10 150 mg 30 mL

11 250 mg 50 mL

12 Then follow scheduled interval 500 mg dosing

Notes: Intravenous increments are administered at 15 minute intervals Infuse doses 1-2 over 10 minutes, doses 3-11 over 15 minutes, and dose 12 over 30 minutes Goal dose 2 g

Dose # Dose Volume Bag/Vial #

1 0.005 mg 1 mL 4 (0.005 mg/mL)

2 0.015 mg 3 mL

3 0.05 mg 1 mL 3 (0.05 mg/mL)

4 0.15 mg 3 mL

5 0.5 mg 1 mL 2 (0.5 mg/mL)

6 1.5 mg 3 mL

7 5 mg 1 mL

1 (5 mg/mL)

8 25 mg 5 mL

9 50 mg 10 mL

10 150 mg 30 mL

11 250 mg 50 mL

12 500 mg 100 mL Pre-manufactured 500 mg/100 mL bag 13 1 g 200 mL

14 Then follow scheduled interval 2 g dosing

Notes: Intravenous increments are administered at 15 minute intervals Infuse doses 1-2 over 10 minutes, doses 3-11 over 15 minutes, dose 12 over 30 minutes, and doses 13-14 over 60 minutes Reference: Pearlman MD, Yashar C, Ernst S, Solomon W. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol. 1996; 174;934-6.

Page 21: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 21 of 26

Nafcillin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g NAFCILLIN vial with 8.3 mL SW, label vial #1 100 mg/mL

2. 0.1 mL of vial 1 plus 9.9 mL SW into an empty vial, labeled #2 1 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 2 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 3 mg 3 mL

7 5 mg 5 mL

8 10 mg 0.1 mL 1 (100 mg/mL)

9 30 mg 0.3 mL

10 50 mg 0.5 mL

11 100 mg 1 mL

12 300 mg over 30 min 3 mL

13 500 mg over 30 min 5 mL

Goal dose 2 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 3 (0.01 mg/mL)

2 0.03 mg 3 mL

3 0.05 mg 5 mL

4 0.1 mg 0.1 mL 2 (1 mg/mL)

5 0.3 mg 0.3 mL

6 0.5 mg 0.5 mL

7 1 mg 1 mL

8 3 mg 3 mL

9 5 mg 5 mL

10 10 mg 0.1 mL 1 (100 mg/mL)

11 30 mg 0.3 mL

12 50 mg 0.5 mL

13 100 mg 1 mL

14 300 mg over 30 min 3 mL

15 500 mg over 30 min 5 mL

16 1 g over 30-60 min Add-Vantage

Page 22: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 22 of 26

Penicillin G

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 5,000,000 unit PENICILLIN G vial with 8 mL SW label vial #1 500,000 units/mL

2. 1 mL of vial 1 plus 9 mL SW into an empty vial, labeled #2 50,000 units/mL

3. 1 mL of vial 2 plus 9 mL SW into an empty vial, labeled #3 5,000 units/mL

4. 1 mL of vial 3 plus 9 mL SW into an empty vial, labeled #4 500 units/mL

5. 1 mL of vial 4 plus 9 mL SW into an empty vial, labeled #5 50 units/mL

6. 1 mL of vial 5 plus 9 mL SW into an empty vial, labeled #6 5 units/mL

STEP 2: PREPARE IV DOSES Goal dose 2.5 million units

Dose # Dose Volume Vial #

1 1 unit 0.2 mL 6 (5 units/mL)

2 5 units 1 mL

3 10 units 2 mL

4 50 units 1 mL 5 (50 units/mL)

5 100 units 2 mL

6 500 units 1 mL 4 (500 units/mL)

7 750 units 1.5 mL

8 1,000 units 2 mL

9 5,000 units 1 mL 3 (5,000 units/mL)

10 7,500 units 1.5 mL

11 10,000 units 2 mL

12 50,000 units 1 mL 2 (50,000 units/mL)

13 75,000 units 1.5 mL

14 100,000 units 2 mL

15 500,000 units 1 mL 1 (500,000 units/mL)

16 750,000 units 1.5 mL

17 1,000,000 units 2 mL

Page 23: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 23 of 26

Penicillin G, continued Goal dose 3 million units

Dose # Dose Volume Vial #

1 1 unit 0.2 mL 6 (5 units/mL)

2 5 units 1 mL

3 10 units 2 mL

4 50 units 1 mL 5 (50 units/mL)

5 100 units 2 mL

6 500 units 1 mL 4 (500 units/mL)

7 750 units 1.5 mL

8 1,000 units 2 mL

9 5,000 units 1 mL 3 (5,000 units/mL)

10 7,500 units 1.5 mL

11 10,000 units 2 mL

12 50,000 units 1 mL 2 (50,000 units/mL)

13 75,000 units 1.5 mL

14 100,000 units 2 mL

15 500,000 units 1 mL 1 (500,000 units/mL)

16 1,000,000 units 2 mL

17 1,250,000 units 2.5 mL

Goal dose 4 million units

Dose # Dose Volume Vial #

1 1 unit 0.2 mL 6 (5 units/mL)

2 5 units 1 mL

3 10 units 2 mL

4 50 units 1 mL 5 (50 units/mL)

5 100 units 2 mL

6 500 units 1 mL 4 (500 units/mL)

7 1,000 units 2 mL

8 5,000 units 1 mL 3 (5,000 units/mL)

9 10,000 units 2 mL

10 30,000 units 0.6 mL 2 (50,000 units/mL)

11 50,000 units 1 mL

12 100,000 units 2 mL

13 300,000 units 0.6 mL 1 (500,000 units/mL)

14 500,000 units 1 mL

15 750,000 units 1.5 mL

16 1,000,000 units 2 mL

17 1,250,000 units 2.5 mL

Page 24: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 24 of 26

Piperacillin/tazobactam (Zosyn)

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 3.375 g ZOSYN vial with 16.9 mL SW label vial #1 200 mg/mL

2. 5 mL of vial 1 plus 5 mL SW into an empty vial, labeled #2 100 mg/mL

3. 0.1 mL of vial 2 plus 9.9 mL SW into an empty vial, labeled #3 1 mg/mL

4. 0.1 mL of vial 3 plus 9.9 mL SW into an empty vial, labeled #4 0.01 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 3.375 g

Goal dose 4.5 g

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 4 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 3 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 5 mg 5 mL

7 10 mg 0.1 mL 2 (100 mg/mL)

8 50 mg 0.5 mL

9 100 mg 1 mL

10 200 mg 2 mL

11 500 mg 2.5 1 (200 mg/mL)

12 1 g 5

13 1.5 g 7.5

Dose # Dose Volume Vial #

1 0.01 mg 1 mL 4 (0.01 mg/mL)

2 0.05 mg 5 mL

3 0.1 mg 0.1 mL 3 (1 mg/mL)

4 0.5 mg 0.5 mL

5 1 mg 1 mL

6 5 mg 5 mL

7 10 mg 0.1 mL 2 (100 mg/mL)

8 50 mg 0.5 mL

9 75 mg 0.75 mL

10 100 mg 1 mL 2 (100 mg/mL)

11 250 mg 2.5 mL

12 500 mg 5 mL

13 750 mg 3.75 mL 1 (200 mg/mL)

14 1250 mg 6.25 mL

15 1.5 g 7.5 mL

Page 25: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Page 25 of 26

Tigecycline

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 2 x 50 mg TIGECYCLINE vials each with 5.3 mL D5W or NS, label both vials #1 10 mg/mL

2. 1 mL of vial 1 plus 9 mL D5W or NS into an empty vial labeled #2 1 mg/mL

3. 1 mL of vial 2 plus 9 mL D5W or NS into an empty vial labeled #3 0.1 mg/mL

4. 1 mL of vial 3 plus 9 mL D5W or NS into an empty vial labeled #4 0.01 mg/mL

STEP 2: PREPARE IV DOSES

Dose # Dose Volume Vial #

1 0.001 mg 0.1 mL 4 (0.01 mg/mL) 2 0.005 mg 0.5 mL

3 0.01 mg 1 mL

4 0.05 mg 5 mL

5 0.1 mg 1 mL 3 (0.1 mg/mL)

6 0.5 mg 5 mL

7 1 mg 1 mL 2 (1 mg/mL)

8 5 mg 5 mL

9 10 mg 1 mL 1 (10 mg/mL) 10 30 mg over 30 min 3 mL

11 50 mg over 30 min 5 mL

Page 26: DESENSITIZATION PROTOCOLS - Michigan MedicineDESENSITIZATION PROTOCOLS See also, UMHHC Policy 07-01-017.Desensitization Policy for Drug Hypersensitivity for Inpatients for information

Antimicrobial Subcommittee Approval: N/A Originated: Unknown

P&T Approval: N/A Last Revised: 02/2017

Revision History:

The recommendations in this guide are meant to serve as treatment guidelines for use at Michigan Medicine facilities. If you are an individual experiencing a medical

emergency, call 911 immediately. These guidelines should not replace a provider’s professional medical advice based on clinical judgment, or be used in lieu of an

Infectious Diseases consultation when necessary. As a result of ongoing research, practice guidelines may from time to time change. The authors of these guidelines

have made all attempts to ensure the accuracy based on current information, however, due to ongoing research, users of these guidelines are strongly encouraged to

confirm the information contained within them through an independent source.

If obtained from a source other than med.umich.edu/asp, please visit the webpage for the most up-to-date document.

Page 26 of 26

Vancomycin

STEP 1: PREPARE AND LABEL SERIAL DILUTIONS

Vial Concentration

1. Dilute 1 g VANCOMYCIN vial with 20 mL SW, label vial #1 50 mg/mL

2. 1 mL of vial 1 plus 9 mL SW into an empty vial, labeled #2 5 mg/mL

3. 1 mL of vial 2 plus 9 mL SW into an empty vial, labeled #3 0.5 mg/mL

4. 1 mL of vial 3 plus 9 mL SW into an empty vial, labeled #4 0.05 mg/mL

STEP 2: PREPARE IV DOSES Goal dose 1 g

Dose # Dose Volume Vial #

1 0.01 mg 0.2 mL 4 (0.05 mg/mL)

2 0.05 mg 1 mL

3 0.1 mg 2 mL

4 0.5 mg 1 mL 3 (0.5 mg/mL)

5 1 mg 2 mL

6 3 mg 6 mL

7 5 mg 1 mL 2 (5 mg/mL)

8 10 mg 2 mL

9 30 mg 6 mL

10 50 mg 1 mL 1 (50 mg/mL)

11 100 mg 2 mL

12 300 mg over 30 min 6 mL

13 500 mg over 60 min Add-Vantage